Loading...
•
Jun 30
Altria Q2 2025 Earnings Report
Altria reported stable results in Q2 2025, with slight revenue decline but improved adjusted EPS.
Key Takeaways
Altria maintained strong profitability in Q2 2025, with revenue slightly down year-over-year but adjusted EPS showing growth. Oral tobacco products drove segment growth, particularly from the on! brand, while smokeable products continued to face volume declines.
Revenue was $6.1B, down 1.7% from Q2 2024
Adjusted EPS increased to $1.44, up 8.3% year-over-year
Net income totaled $2.378B for the quarter
Strong growth from oral tobacco segment, led by on! nicotine pouches
Altria
Altria
Altria Revenue by Segment
Altria Revenue by Geographic Location
Revenue by Segment
Smokeable Products Revenue
CapyFin.comOral Tobacco Products Revenue
CapyFin.comOther Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
Altria narrowed its FY2025 adjusted EPS guidance to a range of $5.35 to $5.45, reflecting a 3.0% to 5.0% growth over FY2024.
Positive Outlook
- Raised the lower end of full-year EPS guidance
- Strong performance in oral tobacco, especially on!
- Cost efficiencies from 2025 initiatives
- Share buybacks reduced outstanding shares, improving per-share metrics
- Lower adjusted tax rate supports earnings growth
Challenges Ahead
- Cigarette shipment volumes continue to decline
- Ongoing pressures from illicit flavored disposable e-vapor products
- Macroeconomic pressures affecting consumer discretionary income
- Litigation and regulatory environment remain dynamic
- NJOY ACE remains excluded from market due to ITC orders
Revenue & Expenses
Visualization of income flow from segment revenue to net income